Aveanna Healthcare

AVAH

Market cap $1.45B

ATLANTA, May 28, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (Nasdaq: AVAH), a leading, diversified home care platform focusing on providing care to medically complex, high-cost patient populations, today announced the repricing of its first lien credit facility and revolving credit facility. The repriced credit facilities provide for a 50 basis point reduction to applicable interest rate margins, as well as an additional reduction of 25 basis points to the applicable margins upon the Borrower obtaining a rating of at least B2 or B from certain credit rating agencies.

Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Aveanna Healthcare (AVAH) or Chemed (CHE). But which of these two stocks is more attractive to value investors?

Aveanna Healthcare Holdings reported strong Q1 2026 results, with EPS and revenue significantly beating expectations and shares rising 14% post-earnings. Q1 2026 was the ninth straight quarter in which AVAH has beaten analysts' earnings expectations and the 14th in which it has topped revenue estimates. Key risks include high debt levels, negative free cash flow in Q1 2026, and insider selling, but AVAH's forward PE of 11.4 and PEG ratio of 0.77 support continued upside.

Aveanna Healthcare Holdings Inc. (AVAH) Q1 2026 Earnings Call Transcript

Aveanna Healthcare NASDAQ: AVAH raised its full-year 2026 outlook after reporting double-digit revenue and adjusted EBITDA growth in the first quarter, citing improved reimbursement rates, higher volumes and operating efficiencies across its three business segments.

The headline numbers for Aveanna (AVAH) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Aveanna Healthcare (AVAH) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.1 per share a year ago.

First Quarter Revenue was $647.9 million, a 15.9% increase over the prior year period First Quarter Net income was $41.7 million compared to $5.2 million for the prior year period Adjusted EBITDA for Q1 2026 was $84.4 million, a 25.2% increase over the prior year period Increased Full Year 2026 Revenue guidance to between $2.56 and $2.58 billion, updated from between $2.54 and $2.56 billion Increased Full Year 2026 Adjusted EBITDA guidance to between $328 and $332 million, updated from between $318 and $322 million ATLANTA, May 14, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three-month period ended April 4, 2026. Jeff Shaner, Chief Executive Officer, commented, “Q1 reflects the strength and resiliency of our business model with an impressive start to 2026.

ATLANTA, May 12, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the William Blair 46th Annual Growth Stock Conference in Chicago on June 2, 2026. Management will present at 2:40pm CST and will also host 1x1 investor meetings that same day. Interested investors and other parties may also listen to a simultaneous webcast of the presentation by logging onto the Investor Relations section of the Company's website at https://ir.aveanna.com/. The online replay will be available for a limited time shortly following the call.

Evaluate the expected performance of Aveanna (AVAH) for the quarter ended March 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.